Garaci E - Search Results

1

Thymosin alpha 1 in the treatment of cancer: from basic research to clinical application.

Garaci E, Pica F, Rasi G, Favalli C. Garaci E, et al. Int J Immunopharmacol. 2000 Dec;22(12):1067-76. doi: 10.1016/s0192-0561(00)00075-8. Int J Immunopharmacol. 2000. PMID: 11137613 Review.

2

Thymosin alpha 1: from bench to bedside.

Garaci E, Favalli C, Pica F, Sinibaldi Vallebona P, Palamara AT, Matteucci C, Pierimarchi P, Serafino A, Mastino A, Bistoni F, Romani L, Rasi G. Garaci E, et al. Ann N Y Acad Sci. 2007 Sep;1112:225-34. doi: 10.1196/annals.1415.044. Epub 2007 Jun 28. Ann N Y Acad Sci. 2007. PMID: 17600290

3

Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha-1.

Matteucci C, Minutolo A, Sinibaldi-Vallebona P, Palamara AT, Rasi G, Mastino A, Garaci E. Matteucci C, et al. Among authors: garaci e. Ann N Y Acad Sci. 2010 Apr;1194:6-19. doi: 10.1111/j.1749-6632.2010.05484.x. Ann N Y Acad Sci. 2010. PMID: 20536445 Review.

4

Historical review on thymosin α1 in oncology: preclinical and clinical experiences.

Garaci E, Pica F, Matteucci C, Gaziano R, D'Agostini C, Miele MT, Camerini R, Palamara AT, Favalli C, Mastino A, Serafino A, Sinibaldi Vallebona P. Garaci E, et al. Expert Opin Biol Ther. 2015;15 Suppl 1:S31-9. doi: 10.1517/14712598.2015.1017466. Epub 2015 Jun 22. Expert Opin Biol Ther. 2015. PMID: 26096345 Review.

5

Thymosin alpha(1) in combination with cytokines and chemotherapy for the treatment of cancer.

Garaci E, Pica F, Sinibaldi-Vallebona P, Pierimarchi P, Mastino A, Matteucci C, Rasi G. Garaci E, et al. Int Immunopharmacol. 2003 Aug;3(8):1145-50. doi: 10.1016/S1567-5769(03)00053-5. Int Immunopharmacol. 2003. PMID: 12860169 Review.

6

Antitumour effect of OM-174 and cyclophosphamide on murine B16 melanoma in different experimental conditions.

D'Agostini C, Pica F, Febbraro G, Grelli S, Chiavaroli C, Garaci E. D'Agostini C, et al. Among authors: garaci e. Int Immunopharmacol. 2005 Jul;5(7-8):1205-12. doi: 10.1016/j.intimp.2005.02.013. Epub 2005 Mar 19. Int Immunopharmacol. 2005. PMID: 15914325

7

Thymosin alpha one restores murine T-cell-mediated responses inhibited by in vivo cocaine administration.

Di Francesco P, Pica F, Marini S, Favalli C, Garaci E. Di Francesco P, et al. Among authors: garaci e. Int J Immunopharmacol. 1992 Jan;14(1):1-9. doi: 10.1016/0192-0561(92)90098-6. Int J Immunopharmacol. 1992. PMID: 1582729

8

Combination therapy with thymosin alpha 1 potentiates the anti-tumor activity of interleukin-2 with cyclophosphamide in the treatment of the Lewis lung carcinoma in mice.

Mastino A, Favalli C, Grelli S, Rasi G, Pica F, Goldstein AL, Garaci E. Mastino A, et al. Among authors: garaci e. Int J Cancer. 1992 Feb 1;50(3):493-9. doi: 10.1002/ijc.2910500327. Int J Cancer. 1992. PMID: 1735618

9

Thymosin alpha 1 potentiates interleukin 2-induced cytotoxic activity in mice.

Mastino A, Favalli C, Grelli S, Innocenti F, Garaci E. Mastino A, et al. Among authors: garaci e. Cell Immunol. 1991 Mar;133(1):196-205. doi: 10.1016/0008-8749(91)90191-d. Cell Immunol. 1991. PMID: 1991327

10

Combination treatment using thymosin alpha 1 and interferon after cyclophosphamide is able to cure Lewis lung carcinoma in mice.

Garaci E, Mastino A, Pica F, Favalli C. Garaci E, et al. Cancer Immunol Immunother. 1990;32(3):154-60. doi: 10.1007/BF01771450. Cancer Immunol Immunother. 1990. PMID: 2126987 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

334 results

Search Page

Filters